These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 16144995)

  • 41. Dimethylarginine dimethylaminohydrolase and endothelial dysfunction in failing hearts.
    Chen Y; Li Y; Zhang P; Traverse JH; Hou M; Xu X; Kimoto M; Bache RJ
    Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2212-9. PubMed ID: 16024577
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
    Tanaka M; Mokhtari GK; Balsam LB; Cooke DT; Kofidis T; Zwierzchonievska M; Robbins RC
    J Heart Lung Transplant; 2005 Apr; 24(4):446-53. PubMed ID: 15797747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Immunolocalisation and activity of DDAH I and II in the heart and modification post-myocardial infarction.
    Gray GA; Patrizio M; Sherry L; Miller AA; Malaki M; Wallace AF; Leiper JM; Vallance P
    Acta Histochem; 2010 Sep; 112(5):413-23. PubMed ID: 19481782
    [TBL] [Abstract][Full Text] [Related]  

  • 44. DDAH-2 alleviates contrast medium iopromide-induced acute kidney injury through nitric oxide synthase.
    Lin HH; Lee TS; Lin SJ; Yeh YC; Lu TM; Hsu CP
    Clin Sci (Lond); 2019 Dec; 133(23):2361-2378. PubMed ID: 31763675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Asymmetric dimethylarginine and cardiac allograft vasculopathy progression: modulation by sirolimus.
    Potena L; Fearon WF; Sydow K; Holweg C; Luikart H; Chin C; Weisshaar D; Mocarski ES; Lewis DB; Valantine HA; Cooke JP
    Transplantation; 2008 Mar; 85(6):827-33. PubMed ID: 18360263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Erythropoietin increases asymmetric dimethylarginine in endothelial cells: role of dimethylarginine dimethylaminohydrolase.
    Scalera F; Kielstein JT; Martens-Lobenhoffer J; Postel SC; Täger M; Bode-Böger SM
    J Am Soc Nephrol; 2005 Apr; 16(4):892-8. PubMed ID: 15728783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of fluid reabsorption in rat or mouse proximal renal tubules by asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase 1.
    Bell T; Araujo M; Luo Z; Tomlinson J; Leiper J; Welch WJ; Wilcox CS
    Am J Physiol Renal Physiol; 2018 Jul; 315(1):F74-F78. PubMed ID: 29513072
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The DDAH/ADMA/NOS pathway.
    Tran CT; Leiper JM; Vallance P
    Atheroscler Suppl; 2003 Dec; 4(4):33-40. PubMed ID: 14664901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ADMA and hyperhomocysteinemia.
    Dayal S; Lentz SR
    Vasc Med; 2005 Jul; 10 Suppl 1():S27-33. PubMed ID: 16444866
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of the endothelial DDAH/ADMA pathway in nitroglycerin tolerance: the role of ALDH-2.
    Zhang GG; Shi RZ; Jiang DJ; Chen YR; Jia-Chen ; Tang ZY; Bai YP; Xiao HB; Li YJ
    Life Sci; 2008 Mar; 82(13-14):699-707. PubMed ID: 18289604
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function.
    Richir MC; Bouwman RH; Teerlink T; Siroen MP; de Vries TP; van Leeuwen PA
    JPEN J Parenter Enteral Nutr; 2008; 32(6):613-21. PubMed ID: 18974239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity.
    Jiang JL; Zhang XH; Li NS; Rang WQ; Feng-Ye ; Hu CP; Li YJ; Deng HW
    Cardiovasc Drugs Ther; 2006 Aug; 20(4):281-94. PubMed ID: 16897158
    [TBL] [Abstract][Full Text] [Related]  

  • 53. L-arginine polymer mediated inhibition of graft coronary artery disease after cardiac transplantation.
    Kown MH; van Der Steenhoven T; Uemura S; Jahncke CL; Hoyt GE; Rothbard JB; Robbins RC
    Transplantation; 2001 Jun; 71(11):1542-8. PubMed ID: 11435962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of DDAH/ADMA/NOS pathway in nicotine-induced endothelial dysfunction.
    Jiang DJ; Jia SJ; Yan J; Zhou Z; Yuan Q; Li YJ
    Biochem Biophys Res Commun; 2006 Oct; 349(2):683-93. PubMed ID: 16959216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Preservation of vascular DDAH activity contributes to the protection of captopril against endothelial dysfunction in hyperlipidemic rabbits.
    Lin Y; Feng M; Lu CW; Lei YP; He ZM; Xiong Y
    Eur J Pharmacol; 2017 Mar; 798():43-48. PubMed ID: 28163022
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Homocysteine increases the production of asymmetric dimethylarginine in cultured neurons.
    Selley ML
    J Neurosci Res; 2004 Jul; 77(1):90-3. PubMed ID: 15197741
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Increased asymmetric dimethylarginine (ADMA) dimethylaminohydrolase (DDAH) activity in childhood hypercholesterolemia type II.
    Chobanyan-Jürgens K; Fuchs AJ; Tsikas D; Kanzelmeyer N; Das AM; Illsinger S; Vaske B; Jordan J; Lücke T
    Amino Acids; 2012 Aug; 43(2):805-11. PubMed ID: 22075968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischaemia in the early phase of diabetic nephropathy.
    Shibata R; Ueda S; Yamagishi S; Kaida Y; Matsumoto Y; Fukami K; Hayashida A; Matsuoka H; Kato S; Kimoto M; Okuda S
    Nephrol Dial Transplant; 2009 Apr; 24(4):1162-9. PubMed ID: 19015171
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The adipose tissue gene expression in mice with different nitric oxide availability.
    Razny U; Kiec-Wilk B; Polus A; Wator L; Dyduch G; Partyka L; Bodzioch M; Tomaszewska R; Wybranska I
    J Physiol Pharmacol; 2010 Oct; 61(5):607-18. PubMed ID: 21081805
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aspirin protected against endothelial damage induced by LDL: role of endogenous NO synthase inhibitors in rats.
    Deng S; Deng PY; Jiang JL; Ye F; Yu J; Yang TL; Deng HD; Li YJ
    Acta Pharmacol Sin; 2004 Dec; 25(12):1633-9. PubMed ID: 15569408
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.